Multimedia |
CME From JCP |
JCP Supplement |
CME From PCC
CME From JCPIn this journal CME activity, find experts’ recommendations for reducing schizophrenia relapse, such as adopting a patient-centered approach, selecting medications based on current evidence, and implementing psychosocial interventions. [top]
The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery
Using Long-Acting Injectable Antipsychotics to Enhance Potential for Recovery From Schizophrenia
Christoph U. Correll, MD, John Lauriello, MD
[Activity] [Posttest] 8/31/2022
JCP CME Activities
Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: a systematic review and meta-analysis
Filipe Peste Martinho, Gonçalo Silva Duarte, Frederico Simões do Couto
[Activity] [Posttest] 5/31/2022
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, Stephen R. Marder, Leslie Citrome, John W. Newcomer, Delbert G. Robinson, Donald C. Goff, Deanna L. Kelly, Oliver Freudenreich, Daria Piacentino, Michael Paulzen, Andreas Conca, Gerald Zernig, Ekkehard Haen, Pierre Baumann, Christoph Hiemke, Gerhard Gründer, for the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrier
[Activity] [Posttest] 6/30/2022
New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature
Emily A. Ferenczi; Michael G. Erkkinen; Mel B. Feany; Barry S. Fogel; Kirk R. Daffner
[Activity] [Posttest] 4/30/2022
Disordered Aggression and Violence in the United States
Emil F. Coccaro, and Royce J. Lee
[Activity] [Posttest] 4/30/2022
The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders
Jozefien M. Overbeek; Nicole Korten; Flora Gossink;
Jay Fieldhouse; Marleen van de Beek; Lianne Reus;
Annemieke Dols; Yolande Pijnenburg; and Sigfried Schouws
[Activity] [Posttest] 2/28/2022
Past Psychiatric Conditions as Risk Factors for Postpartum Depression: A Nationwide Cohort Study
Sara L. Johansen; Ben A. Stenhaug; Thalia K. Robakis; Katherine E. Williams; and Mark R. Cullen
[Activity] [Posttest] 1/31/2022
Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History
Erica L. F. Buchalter; Hanadi Ajam Oughli; Eric J. Lenze;
David Dixon; J. Philip Millera; Daniel M. Blumberger;
Jordan F. Karp; Charles F. Reynolds III; and Benoit H. Mulsant
[Activity] [Posttest] 12/31/2021
Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III
Ty S. Schepis, and Sean Esteban McCabe
[Activity] [Posttest] 11/30/2021
Real World Outcomes in the Management of Refractory Psychosis
Amir Krivoy; Dan Joyce; Derek Tracy; Fiona Gaughran; James MacCabe; John Lally; Whiskey Eromona; S. Neil Sarkar, and Sukhwinder S. Shergill
[Activity] [Posttest] 10/31/2021
Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis
Sally Mustafa; Ridha Joober; Srividya Iyer; Jai Shah; Martin Lepage; Ashok Malla
[Activity] [Posttest] 9/30/2021
High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder
Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A. Axelson; Daniel P. Dickstein, MD; Tina R. Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D. Ryan; Michael A. Strober; Martin B. Keller; and Benjamin I. Goldstein
[Activity] [Posttest] 8/31/2021
Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis
Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter
[Activity] [Posttest] 8/30/2021
Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III
Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant
[Activity] [Posttest] 6/30/2021
Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence
Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky
[Activity] [Posttest] 6/30/2022
Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence
Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll
[Activity] [Posttest] 4/30/2021
Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study
Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu
[Activity] [Posttest] 3/31/2021
Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis
Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn
[Activity] [Posttest] 2/28/2021
Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort
David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group
[Activity] [Posttest] 2/28/2021
Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults
Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg
[Activity] [Posttest] 12/31/2020
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice
Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts
[Activity] [Posttest] 10/31/2020
An Examination of Screening Tools for Collaborative Care of Adolescent Depression
Alexander D. Ginsburg, Paul S. Stadem, Christopher R. Takala, Paul E. Croarkin, Angela B. Mattson, Marcie L. Billings, RoxAnne M. Brennan, and John E. Huxsahl
[Activity] [Posttest] 8/31/2020
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment
Leslie Citrome, MD, MPH; Stephen R. Saklad, PharmD, BCPP
[Activity] [Posttest] 4/30/2022
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia
Joseph P. McEvoy, MD, and Daniel E. Kremens, MD, JD
[Activity] [Posttest] 2/28/2022
A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease
Current and Emerging Solutions to Challenges in the Evaluation and Management of Alzheimer’s Disease
Alireza Atri, MD, PhD (Chair); Danielle Goldfarb, MD; Simon Sheard, DO; and Lynn Shaughnessy, PsyD
[Activity] [Posttest] 12/31/2021
Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia
Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia
John M. Kane, MD, and Christoph U. Correll, MD
[Activity] [Posttest] 10/31/2021
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia
Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care
John Lauriello, MD, and Diana O. Perkins, MD
[Activity] [Posttest] 2/28/2021
Emerging Treatment Strategies for Patients With Tardive Dyskinesia
Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment
Christoph U. Correll, MD (Chair), et al
[Activity] [Posttest] 10/31/2020
CME From PCCIn addition to psychosis, depressive symptoms can occur in patients with anti-NMDAR encephalopathy (ANMDARE). ANDMARE should be considered in patients presenting with psychotic or atypical depressive illnesses. Early recognition of ANMDARE could lead to better management of this potentially life-threatening autoimmune disorder. [top]
PCC CME Activities
Psychiatric Prodrome in Anti-NMDAR–Associated Encephalopathy: Clinical and Pathophysiologic Considerations
Anh-Vu Nguyen, Keith A. Young, James A. Bourgeois
[Activity] [Posttest] 7/31/2022
Organic Psychosis Causing Secondary Schizophrenia in One-Fourth of a Cohort of 200 Patients Previously Diagnosed With Primary Schizophrenia
João Gama Marques
[Activity] [Posttest] 4/30/2022
Glucagon-Like Peptide Analogues Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications: A Retrospective Cohort Study
Lauren T. Perlis; J. Steven Lamberti; and Susanne U. Miedlich
[Activity] [Posttest] 2/28/2022
Hypertensive Urgency and Emergency in Alcohol Withdrawal: A Literature Review
Ermal Bojdani, Anderson Chen, Tina Zhang, Nida Naqvi, Dil Tahera
[Activity] [Posttest] 12/31/2021
No MMSE for You! A case of an ‘uncooperative’ patient with early-onset dementia
Po-Heng Tsai, Gurmehr Kaur, Ganesh Gopalakrishna
[Activity] [Posttest] 10/31/2021
Bridging Community Mental Health and Primary Care to Improve
Medication Monitoring and Outcomes for Patients With Mental
Illness Taking Second-Generation Antipsychotics (HDC/DFMC Bridge
Project—Phase 1: Group Concept Mapping)
Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan
[Activity] [Posttest] 8/31/2021
Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review
Ivan Netto, Vivek H. Phutane, and Bipin Ravindran
[Activity] [Posttest] 6/30/2022
Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach
Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak
[Activity] [Posttest] 4/30/2021
Psychotropic Medication Monitoring: A Review
Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman
[Activity] [Posttest] 2/28/2021
Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder
Mohan Gautam and Deepak Prabhakar
[Activity] [Posttest] 12/31/2020
Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility
Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD
[Activity] [Posttest] 10/31/2020
Posttraumatic Stress Disorder Comorbid with Mood Disorder: Significantly Higher Incidence of Obstructive Sleep Apnea Than Either Diagnosis Alone
Bettina S. Fehr, William F. Katz, Erin A. Van Enkevort, and Imran S. Khawaja
[Activity] [Posttest] 8/31/2020
Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments
Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments
Richard B. Lipton, MD, and Stephen Silberstein, MD
[Activity] [Posttest] 12/31/2020